Catalyzing early ovarian cancer detection: Platelet RNA-based precision screening

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Early detection of ovarian cancer is critical for treatment success, but current methods often diagnose the disease at advanced stages.
• Platelet RNA advancements offer new possibilities for early tumor detection.

Purpose of the Study:

• To develop and validate a two-step RNA-based method for detecting pelvic masses (ovarian or uterine) and assessing their malignancy.
• To improve early diagnosis rates for ovarian and endometrial cancers.

Main Methods:

• Utilized a two-step method employing exon-exon junction features with sampling invariant normalization for pelvic mass detection.
• Employed intron-spanning reads (ISR) counts, rather than gene expression, to model splice junctions.
• Integrated exon-exon junction features with hematology parameters to determine malignancy.

Main Results:

• Achieved >99% specificity in assessing the existence of pelvic masses (ovarian or uterine).
• Demonstrated >99% negative predictive value for ovarian cancer malignancy detection.
• The method shows practical utility for assisting clinicians in further investigations.

Conclusions:

• The proposed RNA-based algorithm shows significant promise for the early detection of ovarian and endometrial cancers.
• This novel approach, using splice junctions from platelet RNA, can complement existing screening methods.
• The high specificity and negative predictive value support its potential clinical application.